Standard BioTools Inc. Common Stock (LAB) is a publicly traded Healthcare sector company. As of May 20, 2026, LAB trades at $1.06 with a market cap of $386.11M and a P/E ratio of -5.13. LAB moved +5.00% today. Year to date, LAB is -19.70%; over the trailing twelve months it is +0.95%. Its 52-week range spans $0.87 to $2.32. Analyst consensus is neutral with an average price target of $1.35. Rallies surfaces LAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Standard BioTools Inc. Common Stock (LAB) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. LAB moved +5.00% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $1.06 |
| Market Cap | $386.11M |
| P/E Ratio | -5.13 |
| EPS | $-0.20 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.32 |
| 52-Week Low | $0.87 |
| Volume | 1.28M |
| Avg Volume | 0 |
| Revenue (TTM) | $85.33M |
| Net Income | $-74.90M |
| Gross Margin | 49.86% |
2 analysts cover LAB: 0 strong buy, 0 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $1.35.